Neptune Technologies & Bioressources Inc. (Neptune) is a biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company operates in three segments: Neptune, Acasti Pharma Inc. and Acasti Pharma Inc. Its Neptune produces and commercializes nutraceutical products. Its Acasti Pharma Inc. develops and commercializes pharmaceutical applications for cardiovascular diseases. Its NeuroBioPharm Inc. develops and commercializes pharmaceutical applications for neurological diseases. It produces omega-3 PUFAs through its patented process of extracting oils from Antartic krill, which omega-3 PUFAs are then principally sold as bulk oil to Neptune's distributors who commercialize them under their private label primarily in the United States, European and Australian nutraceutical markets. The Company's products include Neptune Krill Oil (NKO) and ECOKRILL Oil (EKO).
Industry, Sector and Symbol:
- Sector: N/A
- Industry: N/A
- Sub-Industry: N/A
- Symbol: CVE:NTB
- CUSIP: N/A
- Web: N/A
- Market Cap: C$116.92 million
- Outstanding Shares: 77,945,000
- 50 Day Moving Avg: C$1.53
- 200 Day Moving Avg: C$1.40
- 52 Week Range: C$77,945,000.00 - C$1.08
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
Frequently Asked Questions for Neptune Technologies & Bioressources (CVE:NTB)
What is Neptune Technologies & Bioressources' stock symbol?
Neptune Technologies & Bioressources trades on the Canadian Venture Exchange (CVE) under the ticker symbol "NTB."
How were Neptune Technologies & Bioressources' earnings last quarter?
Neptune Technologies & Bioressources Inc (CVE:NTB) released its quarterly earnings results on Tuesday, July, 15th. The company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.08) by $0.02. The firm had revenue of $3.69 million for the quarter, compared to analysts' expectations of $7.31 million. View Neptune Technologies & Bioressources' Earnings History.
Who are some of Neptune Technologies & Bioressources' key competitors?
Some companies that are related to Neptune Technologies & Bioressources include WesternZagros Resources (WZR), Input Capital Corp (INP), Sterling Resources Ltd (SLG), Strategic Oil & Gas Ltd (SOG), NYX Gaming Group Ltd (NYX), BSM Technologies (GPS), Orezone Gold Corp (ORE), Madalena Energy (MVN), Titanium Co. (TIC), Mosaic Capital Corp (M), Pan Orient Energy Corp. (POE), Canamax Energy Ltd (CAC), Atico Mining Corp (ATY), Luna Gold Corp (LGC), Conifex Timber (CFF), Africa Energy Corp (AFE), Ikkuma Resources Corp (IKM) and Atacama Pacific Gold (ATM).
How do I buy Neptune Technologies & Bioressources stock?
Shares of Neptune Technologies & Bioressources and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
How much does a share of Neptune Technologies & Bioressources stock cost?
One share of Neptune Technologies & Bioressources stock can currently be purchased for approximately C$1.50.
Consensus Ratings for Neptune Technologies & Bioressources (CVE:NTB) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||No ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for Neptune Technologies & Bioressources (CVE:NTB)
No equities research coverage for this company has been tracked by MarketBeat.com
Earnings History for Neptune Technologies & Bioressources (CVE:NTB)Earnings History by Quarter for Neptune Technologies & Bioressources (CVE:NTB)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|7/15/2014||($0.08)||($0.06)||$7.31 million||$3.69 million||View||N/A|
|5/21/2014||($0.08)||($0.08)||$6.36 million||$3.67 million||View||N/A|
Earnings Estimates for Neptune Technologies & Bioressources (CVE:NTB)
Current Year EPS Consensus Estimate: $0.02 EPS
Dividend History for Neptune Technologies & Bioressources (CVE:NTB)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Neptune Technologies & Bioressources (CVE:NTB)Insider Trades by Quarter for Neptune Technologies & Bioressources (CVE:NTB)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|2/1/2016||James Stuart Hamilton||Director||Buy||4,000||C$1.58||C$6,320.00|
|1/28/2016||James Stuart Hamilton||Director||Buy||2,000||C$1.55||C$3,100.00|
|1/15/2016||John Morris Moretz||Director||Buy||700,651||C$1.05||C$735,683.55|
|10/29/2015||John Morris Moretz||Director||Buy||26,044||C$1.08||C$28,101.48|
|10/28/2015||John Morris Moretz||Director||Buy||24,500||C$1.12||C$27,538.00|
|10/27/2015||John Morris Moretz||Director||Buy||5,500||C$1.09||C$6,006.00|
|10/23/2015||John Morris Moretz||Director||Buy||50,000||C$1.17||C$58,385.00|
|10/5/2015||John Morris Moretz||Director||Buy||13,692||C$1.24||C$16,991.77|
|10/2/2015||John Morris Moretz||Director||Buy||33,900||C$1.23||C$41,663.10|
|9/15/2015||John Morris Moretz||Director||Buy||9,001||C$1.24||C$11,161.24|
|7/22/2015||John Morris Moretz||Director||Buy||2,800||C$1.34||C$3,750.60|
|7/21/2015||John Morris Moretz||Director||Buy||21,654||C$1.34||C$28,975.22|
|1/30/2015||Bel Dominique Le||Insider||Sell||15,000||C$2.30||C$34,500.00|
|1/29/2015||Bel Dominique Le||Insider||Sell||10,000||C$2.25||C$22,500.00|
Headline Trends for Neptune Technologies & Bioressources (CVE:NTB)
Latest Headlines for Neptune Technologies & Bioressources (CVE:NTB)
Neptune Technologies & Bioressources (NTB) Chart for Thursday, May, 25, 2017